1. Fujita T and Narumiya S (2016) Roles of hepatic stellate cells in liver inflammation: a new perspective. Inflamm Regen 36:1. doi: 10.1186/s41232-016-0005-6
2. Puche JE, Saiman Y and Friedman SL (2013) Hepatic stellate cells and liver fibrosis. Compr Physiol 3:1473-92. doi: 10.1002/cphy.c120035
3. Gandhi CR (2017) Hepatic stellate cell activation and pro-fibrogenic signals. J Hepatol 67:1104-1105. doi: 10.1016/j.jhep.2017.06.001
4. Watanabe A, Sohail MA, Gomes DA, Hashmi A, Nagata J, Sutterwala FS, Mahmood S, Jhandier MN, Shi Y, Flavell RA and Mehal WZ (2009) Inflammasome-mediated regulation of hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 296:G1248-57. doi: 10.1152/ajpgi.90223.2008
5. Lin KM, Hu W, Troutman TD, Jennings M, Brewer T, Li X, Nanda S, Cohen P, Thomas JA and Pasare C (2014) IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation. Proc Natl Acad Sci U S A 111:775-80. doi: 10.1073/pnas.1320294111
6. Zhou H, Zhao K, Li W, Yang N, Liu Y, Chen C and Wei T (2012) The interactions between pristine graphene and macrophages and the production of cytokines/chemokines via TLR- and NF-kappaB-related signaling pathways. Biomaterials 33:6933-42. doi: 10.1016/j.biomaterials.2012.06.064
7. Franchi L, Eigenbrod T and Nunez G (2009) Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 183:792-6. doi: 10.4049/jimmunol.0900173
8. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, Hornung V and Latz E (2009) Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 183:787-91. doi: 10.4049/jimmunol.0901363
9. Lee J, Mira-Arbibe L and Ulevitch RJ (2000) TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide. J Leukoc Biol 68:909-15.
10. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T, Matsumoto K, Takeuchi O and Akira S (2005) Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 6:1087-95. doi: 10.1038/ni1255
11. Chen Z, Liu Y, Sun B, Li H, Dong J, Zhang L, Wang L, Wang P, Zhao Y and Chen C (2014) Polyhydroxylated metallofullerenols stimulate IL-1beta secretion of macrophage through TLRs/MyD88/NF-kappaB pathway and NLRP(3) inflammasome activation. Small 10:2362-72. doi: 10.1002/smll.201302825
12. Piccini A, Carta S, Tassi S, Lasiglie D, Fossati G and Rubartelli A (2008) ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci U S A 105:8067-72. doi: 10.1073/pnas.0709684105
13. Munoz-Planillo R, Kuffa P, Martinez-Colon G, Smith BL, Rajendiran TM and Nunez G (2013) K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38:1142-53. doi: 10.1016/j.immuni.2013.05.016
14. Murakami T, Ockinger J, Yu J, Byles V, McColl A, Hofer AM and Horng T (2012) Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc Natl Acad Sci U S A 109:11282-7. doi: 10.1073/pnas.1117765109
15. Lawlor KE and Vince JE (2014) Ambiguities in NLRP3 inflammasome regulation: is there a role for mitochondria? Biochim Biophys Acta 1840:1433-40. doi: 10.1016/j.bbagen.2013.08.014
16. Elliott EI and Sutterwala FS (2015) Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev 265:35-52. doi: 10.1111/imr.12286
17. Chu J, Thomas LM, Watkins SC, Franchi L, Nunez G and Salter RD (2009) Cholesterol-dependent cytolysins induce rapid release of mature IL-1beta from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner. J Leukoc Biol 86:1227-38. doi: 10.1189/jlb.0309164
18. Inoue Y, Sadatomo A and Takahashi M (2015) Role of NLRP3 Inflammasomes in Hepatic Ischemia-reperfusion Injury. Inflammation and Regeneration 35:061-068. doi: 10.2492/inflammregen.35.061
19. Wang H, Liu S, Wang Y, Chang B and Wang B (2016) Nod-like receptor protein 3 inflammasome activation by Escherichia coli RNA induces transforming growth factor beta 1 secretion in hepatic stellate cells. Bosn J Basic Med Sci 16:126-31. doi: 10.17305/bjbms.2016.699
20. Duan NN, Liu XJ and Wu J (2017) Palmitic acid elicits hepatic stellate cell activation through inflammasomes and hedgehog signaling. Life Sci 176:42-53. doi: 10.1016/j.lfs.2017.03.012
21. Szabo G and Petrasek J (2015) Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol 12:387-400. doi: 10.1038/nrgastro.2015.94
22. Mridha AR, Wree A, Robertson AAB, Yeh MM, Johnson CD, Van Rooyen DM, Haczeyni F, Teoh NC, Savard C, Ioannou GN, Masters SL, Schroder K, Cooper MA, Feldstein AE and Farrell GC (2017) NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol 66:1037-1046. doi: 10.1016/j.jhep.2017.01.022
23. Gieling RG, Wallace K and Han YP (2009) Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol 296:G1324-31. doi: 10.1152/ajpgi.90564.2008
24. Ono K, Ohtomo T, Ninomiya-Tsuji J and Tsuchiya M (2003) A dominant negative TAK1 inhibits cellular fibrotic responses induced by TGF-beta. Biochem Biophys Res Commun 307:332-7.
25. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E and Matsumoto K (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270:2008-11.
26. Kim SI, Kwak JH, Zachariah M, He Y, Wang L and Choi ME (2007) TGF-beta-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-beta1-induced MKK3-p38 MAPK activation and stimulation of type I collagen. Am J Physiol Renal Physiol 292:F1471-8. doi: 10.1152/ajprenal.00485.2006
27. Akiyama T, Shinzawa M and Akiyama N (2012) TNF receptor family signaling in the development and functions of medullary thymic epithelial cells. Front Immunol 3:278. doi: 10.3389/fimmu.2012.00278
28. Wei XF, Zhou QG, Hou FF, Liu BY and Liang M (2009) Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase. Am J Physiol Renal Physiol 296:F427-37. doi: 10.1152/ajprenal.90536.2008
29. Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S and Sorescu D (2005) NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 97:900-7. doi: 10.1161/01.RES.0000187457.24338.3D
30. Sampson N, Berger P and Zenzmaier C (2014) Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic disease. Biomed Res Int 2014:131737. doi: 10.1155/2014/131737
31. Xing Y, Yao X, Li H, Xue G, Guo Q, Yang G, An L, Zhang Y and Meng G (2017) Cutting Edge: TRAF6 Mediates TLR/IL-1R Signaling-Induced Nontranscriptional Priming of the NLRP3 Inflammasome. J Immunol 199:1561-1566. doi: 10.4049/jimmunol.1700175
32. Liu T, Zhang L, Joo D and Sun SC (2017) NF-kappaB signaling in inflammation. Signal Transduct Target Ther 2. doi: 10.1038/sigtrans.2017.23
33. Xu J, Lu L and Li L (2016) NEK7: a novel promising therapy target for NLRP3-related inflammatory diseases. Acta Biochim Biophys Sin (Shanghai) 48:966-968. doi: 10.1093/abbs/gmw080
34. He Y, Zeng MY, Yang D, Motro B and Nunez G (2016) NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530:354-7. doi: 10.1038/nature16959
35. Al Mamun A, Akter A, Hossain S, Sarker T, Safa SA, Mustafa QG, Muhammad SA and Munir F (2020) Role of NLRP3 inflammasome in liver disease. J Dig Dis 21:430-436. doi: 10.1111/1751-2980.12918
36. Dewidar B, Meyer C, Dooley S and Meindl-Beinker AN (2019) TGF-beta in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019. Cells 8. doi: 10.3390/cells8111419
37. Choi ME, Ding Y and Kim SI (2012) TGF-beta signaling via TAK1 pathway: role in kidney fibrosis. Semin Nephrol 32:244-52. doi: 10.1016/j.semnephrol.2012.04.003
38. Stambe C, Atkins RC, Tesch GH, Masaki T, Schreiner GF and Nikolic-Paterson DJ (2004) The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol 15:370-9. doi: 10.1097/01.asn.0000109669.23650.56
39. Lambeth JD (2004) NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4:181-9. doi: 10.1038/nri1312
40. Wu X, Zhang H, Qi W, Zhang Y, Li J, Li Z, Lin Y, Bai X, Liu X, Chen X, Yang H, Xu C, Zhang Y and Yang B (2018) Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis. Cell Death Dis 9:171. doi: 10.1038/s41419-017-0257-3
41. Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND and Zhao YY (2018) New insights into TGF-beta/Smad signaling in tissue fibrosis. Chem Biol Interact 292:76-83. doi: 10.1016/j.cbi.2018.07.008
42. Luo DD, Fielding C, Phillips A and Fraser D (2009) Interleukin-1 beta regulates proximal tubular cell transforming growth factor beta-1 signalling. Nephrol Dial Transplant 24:2655-65. doi: 10.1093/ndt/gfp208
43. Grebe A, Hoss F and Latz E (2018) NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis. Circ Res 122:1722-1740. doi: 10.1161/CIRCRESAHA.118.311362
44. Zhang Y, Dong Z and Song W (2020) NLRP3 inflammasome as a novel therapeutic target for Alzheimer's disease. Signal Transduct Target Ther 5:37. doi: 10.1038/s41392-020-0145-7
45. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ and Golenbock DT (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9:857-65. doi: 10.1038/ni.1636